1. Home
  2. AMWL vs STRO Comparison

AMWL vs STRO Comparison

Compare AMWL & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$3.96

Market Cap

111.4M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$8.50

Market Cap

94.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
STRO
Founded
2006
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.4M
94.9M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
AMWL
STRO
Price
$3.96
$8.50
Analyst Decision
Hold
Hold
Analyst Count
7
7
Target Price
$8.33
$19.67
AVG Volume (30 Days)
109.3K
108.6K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$265,023,000.00
$105,646,000.00
Revenue This Year
N/A
$62.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.33
N/A
52 Week Low
$3.71
$5.23
52 Week High
$12.95
$30.10

Technical Indicators

Market Signals
Indicator
AMWL
STRO
Relative Strength Index (RSI) 36.58 86.62
Support Level $3.98 $0.72
Resistance Level $4.22 $9.38
Average True Range (ATR) 0.20 0.43
MACD 0.07 0.96
Stochastic Oscillator 51.85 90.29

Price Performance

Historical Comparison
AMWL
STRO

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: